TB Notes Newsletter

Return to Main Menu - TB Notes 3, 2007

No. 3, 2007

NEW CDC PUBLICATIONS

Akksilp S, Karnkawinpong O, Wattanaa- mornkiat W, Viriyakitja D, Monkongdee P, Sitti W, Rienthong D, Siraprapasiri T, Wells CD, Tappero JW, and Varma JK. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerging Infectious Diseases 2007 Jul; 13 (7): 1001-1007.

Benator DA, Weiner MH, Burman WJ, Vernon AA, Zhao ZA, Khan AE, Jones BE, Sandman L, Engle M, Silva-Trigo C, Hsyu PH, Becker MI, Peloquin CA, for the Tuberculosis Trials Consortium. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection. Pharmacotherapy 2007 Jun; 27(6):793-800.

CDC. Deportation of tuberculosis patients complicated by a medication shortage--Honduras, May-August 2006. MMWR 2007 Jul 6; 56(26):655-8.

Cooksey RC, de Waard JH, Yakrus MA, Toney SR, Da Mata O, Nowicki S, Sohner K, Koch E, Petti CA, Morey RE, Srinivasan A. Mycobacterium cosmeticum, Ohio and Venezuela [letter]. Emerg Infect Dis 2007 Aug; 13 (8): 1267-1269.

Driver CR, Kreiswirth B, Macaraig M, Clark C, Munsiff SS, Driscoll J, Zhao B. Molecular epidemiology of tuberculosis after declining incidence, New York City, 2001-2003. Epidemiology & Infection 2007 May; 135(4): 634-643.

Ferroussier O, Kumar MKA, Dewan PK, Nair PKJ, Sahu S, Wares DF, Laserson K, Wells C, Granich R, Chauhan LS. Cost and cost-effectiveness of a public-private mix project in Kannur District, Kerala, India, 2001-2002. Int J Tuberc Lung Dis 2007; 11 (7): 755-761.

Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Bernardo J, Venkataramanan R, Sterling TR on behalf of the ATS Hepatotoxicity of Antituberculosis Therapy Subcommittee. Antituberculosis Drugs and Hepatotoxicity. [Letter.] Am J Respir Crit Care Med 2007; 175: 858a-859.

Schneider DL and Lobato MN. Tuberculosis control among people in U.S. Immigration and Customs Enforcement custody. American Journal of Preventive Medicine 2007 July; 33 (1): 9-14.

Weiner M, Burman W, Luo C-C, Peloquin CA, Engle M, Goldberg S,  Agarwal V, and Vernon A. Effects of rifampin and multidrug-resistance gene polymorphism on concentrations of moxifloxacin. Antimicrobial Agents and Chemotherapy 2007 August; 51 (8): 2861-2866.

Zhao Z. Early stopping clinical trials of binomial response with an exact group sequential method. Statistics in Medicine 2007 Apr 15; 26(8):1724-1729.

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 
Back to Top of Page

If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov

Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov